Effect of Moringa oleifera Leaf Capsules on Glycemic Control in Therapy-Naïve Type 2 Diabetes Patients: A Randomized Placebo Controlled Study

Table 2

Clinical and glucose parameter in MO leaf and placebo group.

	MO leaf	Placebo	value	value
Body weight (kg)
(i) Baseline			0.49
(ii) 2nd week			0.51
(iii) End of study			0.52	0.12
SBP (mmHg)
(i) Baseline			0.36
(ii) 2nd week			0.14
(iii) End of study			0.68	0.25
DBP (mmHg)
(i) Baseline			0.03
(ii) 2nd week			0.11
(iii) End of study			0.94	0.17
FPG (mg/dl)
(i) Baseline			0.14
(ii) 2nd week			0.33
(iii) End of study			0.44	1.00
HbA1C (%)
(i) Baseline			0.49
(ii) End of study			0.37	0.82

MO leaf, Moringa oleifera leaf; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1C, hemoglobin A1C; PG, plasma glucose; value compare between MO leaf and placebo; value compare between baseline and end of study.